Chemocentryx Historical Income Statement

CCXI -  USA Stock  

USD 14.37  0.62  4.14%

Historical analysis of Chemocentryx income statement accounts such as Interest Expense of 2.9 M, Operating Expenses of 98.9 M or Revenues of 54.5 M can show how well Chemocentryx performed in making a profits. Evaluating Chemocentryx income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Chemocentryx's future profits or losses. Financial Statement Analysis is much more than just reviewing and examining Chemocentryx latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Chemocentryx is a good buy for the upcoming year.
Continue to Trending Equities.

Search Historical Statements 

 
Refresh

Chemocentryx Net Income

(56.81 Million)Share

About Chemocentryx Income Statement Analysis

Chemocentryx Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Chemocentryx shareholders. The income statement also shows Chemocentryx investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Chemocentryx Income Statement Chart

Chemocentryx Income Statement is one of the three primary financial statements used for reporting Chemocentryx's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Chemocentryx revenue and expense. Chemocentryx Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Chemocentryx Interest Expense is most likely to increase significantly in the upcoming years. The last year's value of Interest Expense was reported at 2.64 Million. The current Selling General and Administrative Expense is estimated to increase to about 45.5 M, while Consolidated Income is projected to decrease to (56.8 M).

Consolidated Income

The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of Net Income Available to Non-controlling Interests.

Earning Before Interest and Taxes EBIT

Earnings Before Interest and Tax is calculated by adding Income Tax Expense and Interest Expense back to Net Income.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Chemocentryx financial statement analysis. It represents the amount of money remaining after all of Chemocentryx operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Net Income Common Stock

The amount of net income (loss) for the period due to common shareholders. Typically differs from Net Income to the parent entity due to the deduction of Preferred Dividends.

Revenues

Revenues refers to the total amount of money received by Chemocentryx for goods sold or services provided during a certain time period. It also includes all of Chemocentryx sales as well as any other increase in Chemocentryx equity.Revenues are reported on Chemocentryx income statement and calculated before any expenses are subtracted. Amount of Revenue recognized from goods sold; services rendered; insurance premiums; or other activities that constitute an earning process. Interest income for financial institutions is reported net of interest expense and provision for credit losses.
Most accounts from Chemocentryx income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Chemocentryx current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Trending Equities.Chemocentryx Interest Expense is most likely to increase significantly in the upcoming years. The last year's value of Interest Expense was reported at 2.64 Million. The current Selling General and Administrative Expense is estimated to increase to about 45.5 M, while Consolidated Income is projected to decrease to (56.8 M).
 2018 2019 2020 2021 (projected)
Interest Expense1.22 M2.15 M2.64 M2.85 M
Gross Profit42.88 M36.13 M64.89 M54.5 M

Chemocentryx income statement Correlations

Chemocentryx Account Relationship Matchups

Chemocentryx income statement Accounts

201620172018201920202021 (projected)
Consolidated Income(39.96 M)17.86 M(37.97 M)(55.49 M)(55.36 M)(56.81 M)
Earning Before Interest and Taxes EBIT(39.96 M)17.86 M(36.74 M)(53.34 M)(52.71 M)(54.1 M)
Earning Before Interest and Taxes USD(39.96 M)17.86 M(36.74 M)(53.34 M)(52.71 M)(54.1 M)
Net Income(39.96 M)17.86 M(37.97 M)(55.49 M)(55.36 M)(56.81 M)
Net Income Common Stock(39.96 M)17.86 M(37.97 M)(55.49 M)(55.36 M)(56.81 M)
Net Income Common Stock USD(39.96 M)17.86 M(37.97 M)(55.49 M)(55.36 M)(56.81 M)
Operating Expenses52.66 M66 M83.14 M94.43 M120.07 M98.9 M
Operating Income(40.72 M)16.49 M(40.27 M)(58.3 M)(55.18 M)(56.63 M)
Research and Development Expense37.95 M49.49 M62.74 M70.28 M77.88 M67.06 M
Selling General and Administrative Expense14.71 M16.51 M20.41 M24.16 M42.19 M45.52 M
Weighted Average Shares46.43 M48.41 M49.81 M56.9 M65.69 M57.68 M
Weighted Average Shares Diluted46.43 M49.62 M49.81 M56.9 M65.69 M57.74 M

Chemocentryx Investors Sentiment

The influence of Chemocentryx's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Chemocentryx. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - CCXI

Chemocentryx Investor Sentiment

Most of Macroaxis users are currently bullish on Chemocentryx. What is your opinion about investing in Chemocentryx? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with Chemocentryx

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemocentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemocentryx will appreciate offsetting losses from the drop in the long position's value.

Chemocentryx Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Chemocentryx and Dynavax Technologies. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Trending Equities. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.